Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL12P12 is a processed **pseudogene** derived from the ribosomal protein L12 gene (RPL12). Pseudogenes are non-functional genomic segments that resemble known genes but cannot produce functional protein, often due to disabling mutations or lack of necessary regulatory elements. The RPL12P12 locus does not encode a functional protein and is one of many ribosomal protein pseudogenes dispersed throughout the human genome, thought to arise from retrotransposition events[5][2][6]. While the parent gene RPL12 is involved in assembly of the 60S ribosomal subunit and catalysis of protein synthesis[1][3], its pseudogenes do not contribute directly to these activities. There is currently no evidence that RPL12P12 acts as a biomarker, drug target, or has significant disease relevance. If you are seeking information on a therapeutic target or receptor, this entry does **not** meet those criteria. The proper functional protein would be “60S ribosomal protein L12” (RPL12), not RPL12P12[1][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 12 (RPL12P12).